About the Journal
The International Journal of Medical and Allied Health Sciences (IJMAHS) is a peer-reviewed scholarly journal dedicated to the publication of high-quality research in the fields of medical sciences and allied healthcare sciences disciplines. The journal provides an academic platform for researchers, clinicians, academicians, and healthcare professionals to share innovative research findings and scientific knowledge that contribute to the advancement of healthcare and medical practices. The journal publishes original research articles, review papers, case studies, and short communications covering various aspects of medicine, healthcare, and allied health sciences. By encouraging multidisciplinary and interdisciplinary research, IJMAHS aims to facilitate the exchange of scientific ideas and promote developments in clinical practice, public health, and medical education.
The journal is published by the Society for Medikus and Allied Health Care, Uttar Pradesh, India.
Title: International Journal of Medical and Allied Health Sciences
ISSN: 2583-1879
Frequency: Quarterly
Journal Website: https://www.ijmahs.org
Editorial Email: editor@ijmahs.org
Scope
The scope of IJMAHS covers a wide range of topics in medical and allied health sciences, including but not limited to:
◼ General Medicine and Clinical Research
◼ Public Health and Community Health
◼ Nursing and Healthcare Management
◼ Pharmacy and Pharmaceutical Sciences
◼ Physiotherapy and Rehabilitation Sciences
◼ Medical Laboratory Technology
◼ Radiology and Imaging Sciences
◼ Biomedical and Life Sciences
◼ Nutrition and Dietetics
◼ Epidemiology and Preventive Medicine
◼ Healthcare Policy and Medical Education
◼ Allied Healthcare and Interdisciplinary Medical Research
The journal encourages submissions from researchers and professionals working in multidisciplinary areas of healthcare and medical sciences that contribute to improving health outcomes and advancing medical knowledge.
Types of Articles Accepted
The journal accepts the following manuscript types:
■ Original Research Articles – Full-length papers presenting novel experimental results or significant theoretical contributions
■ Review Articles – Comprehensive and critical reviews of recent developments in animal biotechnology
■ Case Studies – Detailed analyses of real-world applications and field-based innovations
■ Short Communications – Brief reports of significant and timely research findings
Key Commitments
■ Global Reach – Encouraging submissions from researchers across the world
■ Current Relevance – Emphasizing research addressing emerging challenges and innovations in animal biotechnology
■ Quality Assurance – Ensuring academic excellence through a rigorous double-blind peer-review process
Ethics and Publishing Policies
■ Journal Ethics: Adherence to strict ethical standards on plagiarism, authorship, conflicts of interest, and data integrity.
■ Open Access: Immediate, free access to all published content.
■ Repository Policy: Authors may deposit articles in repositories and personal websites.
■ Licensing: Articles are published under CC BY-NC-SA 4.0. Authors retain copyright.
■ Plagiarism Policy: Zero tolerance; all submissions are screened using iThenticate or equivalent tools.
■ AI Policy: Use of AI tools must be transparently disclosed.
■ Digital Archiving: Long-term preservation via services such as Portico or CLOCKSS.
■ Advertising Policy: Only ethical, academic-relevant advertisements are accepted.
■ Ahead of Print: Accepted articles are published online with DOI before issue assignment.
Current Issue
Vol.6, Issue.2 (2026)
Aim:
To detect Mycobacterium tuberculosis and evaluate its Rifampicin resistance using CBNAAT in patients at District, Hospital Gonda who exhibit TB symptoms but have negative sputum test results.
Material and Method:
In the Department of Pulmonary Medicine at District Hospital, Gonda, we performed a retrospective study to assess the utility of CBNAAT over the period from March 2022 to February 2023. The study encompassed all patients who underwent CBNAAT testing during this timeframe. Prior to CBNAAT/RIF testing, sputum samples were first examined using Acid Fast Bacilli (AFB) smear microscopy. These tests were conducted at diagnostic centers equipped for CBNAAT/RIF testing. Data collection and organization were carried out using Microsoft Excel, and the analysis was performed with SPSS 20.0.
Results:
During the study period, 120 sputum samples underwent CBNAAT testing. Out of these, 98 cases (81.7%) yielded negative results and 22 cases (18.3%) were positive. Among the suspected TB instances, 14 (63.6%) were male and 8 (36.4%) were female. A resistance rate of 13.6% (3 cases) was observed for rifampicin.
Conclusion:
CBNAAT has established itself as a trustworthy diagnostic method for individuals suspected of having tuberculosis despite negative sputum results, offering notable sensitivity, specificity, and prompt result generation. Essential in the present scenario marked by a growing burden of pulmonary tuberculosis infections is the imperative need to address the escalating rates of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis.
Published:
23-07-2026
